Alzheimer's Disease Multiple Intervention Trial
ADMIT
1 other identifier
interventional
180
1 country
1
Brief Summary
The purpose of this study is to conduct a two-year randomized, controlled clinical trial to improve functioning among older adults with Alzheimer's disease by comparing a control group receiving best practices primary care with an intervention group receiving best practice primary care plus a home-based occupational therapy intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 10, 2011
CompletedFirst Posted
Study publicly available on registry
March 15, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMarch 8, 2016
March 1, 2016
5.4 years
March 10, 2011
March 7, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS - ADLI)
24 months
Secondary Outcomes (13)
Short Physical Performance Battery (SPPB)
Baseline, 6 months, 12 months, 18 months, and 24 months
Tandem Stand, eyes closed
Baseline, 6 months, 12 months, 18 months, and 24 months
One Leg Stand, eyes open
Baseline, 6 months, 12 months, 18 months, and 24 months
Mini Mental State Examination
Baseline, 6 months, 12 months, 18 months, and 24 months
Word List Learning
Baseline, 6 months, 12 months, 18 months, and 24 months
- +8 more secondary outcomes
Study Arms (2)
Best practices primary care
ACTIVE COMPARATORBest practices primary care encompasses the collaborative care intervention tested in a prior clinical trial (Callahan CM et al. JAMA 2006).
Home based occupational therapy
EXPERIMENTALThe intervention group receives all of the components of best practice primary care in addition to a home-based intervention designed to slow functional decline.
Interventions
An occupational therapist (OT) will deliver the home-based intervention. There are three cycles of intervention over two years, with each cycle delivering eight 60-90 minute home sessions. Cycle one takes place over 16 weeks, cycle two over 32 weeks, and cycle three over one year. Telephone calls take place in intervening weeks, with additional phone calls allowed to assist with problem solving and interval problems. At minimum, the OT will perform an assessment at the beginning of each cycle in order to tailor the home based component for individual dyads at each cycle. The OT will collaborate with the patients and caregivers to develop client centered goals with "homework" each week in order to encourage carryover of strategies, home environmental modifications, or home exercise programs.
Collaborative care is provided by an advanced practice nurse working in collaborations with a family caregiver, the primary care physician, and geriatric medicine specialists. Caregivers complete a formal assessment of problematic behaviors to assess current symptoms and stressors, and the care manager makes recommendations based on these results and using standardized protocols. Protocols focus first on non-pharmacologic interventions. If these interventions fail, the care manager collaborates with the primary care physician and/or specialists to institute protocol-based drug therapy or other strategies. Patients and caregivers are also offered access to support groups.
Eligibility Criteria
You may qualify if:
- Currently a patient within Wishard Health Services in Central Indiana
- Diagnosed with possible or probable Alzheimer's Disease
- Age 45 or older
- English speaking
- Hear well enough to answer questions in person or by telephone
- Community-dwelling (includes senior communities, but not skilled nursing facilities)
- Caregiver willing to participate in the study
- Willing to receive home visits
- Lives in Indianapolis metro area and planning to continue care at primary care clinic
- Age 18 or older
- English speaking
- Hear well enough to answer questions in person or by telephone
- Community-dwelling
- Willing to receive home visits
You may not qualify if:
- Not a current patient within Wishard Health Services
- Does not speak English
- Currently enrolled in another study
- Non-community dwelling, or residing in a skilled nursing facility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- National Institute on Aging (NIA)collaborator
- Regenstrief Institute, Inc.collaborator
Study Sites (1)
Wishard Health Services
Indianapolis, Indiana, 46202, United States
Related Publications (5)
Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Counsell SR, Hendrie HC. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006 May 10;295(18):2148-57. doi: 10.1001/jama.295.18.2148.
PMID: 16684985BACKGROUNDCallahan CM, Boustani M, Sachs GA, Hendrie HC. Integrating care for older adults with cognitive impairment. Curr Alzheimer Res. 2009 Aug;6(4):368-74. doi: 10.2174/156720509788929228.
PMID: 19689236BACKGROUNDGuerriero Austrom M, Damush TM, Hartwell CW, Perkins T, Unverzagt F, Boustani M, Hendrie HC, Callahan CM. Development and implementation of nonpharmacologic protocols for the management of patients with Alzheimer's disease and their families in a multiracial primary care setting. Gerontologist. 2004 Aug;44(4):548-53. doi: 10.1093/geront/44.4.548.
PMID: 15331812BACKGROUNDCallahan CM, Boustani MA, Schmid AA, LaMantia MA, Austrom MG, Miller DK, Gao S, Ferguson DY, Lane KA, Hendrie HC. Targeting Functional Decline in Alzheimer Disease: A Randomized Trial. Ann Intern Med. 2017 Feb 7;166(3):164-171. doi: 10.7326/M16-0830. Epub 2016 Nov 22.
PMID: 27893087DERIVEDCallahan CM, Boustani MA, Schmid AA, Austrom MG, Miller DK, Gao S, Morris CS, Vogel M, Hendrie HC. Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial. Trials. 2012 Jun 27;13:92. doi: 10.1186/1745-6215-13-92.
PMID: 22737979DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher M Callahan, MD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2011
First Posted
March 15, 2011
Study Start
July 1, 2010
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 8, 2016
Record last verified: 2016-03